Practices using the eRelevance patient marketing service to promote procedures using devices manufactured by BTL Aesthetics were able to pay off their devices in less than 6 months, rather than the average 9 months.
This conclusion is the result of data collected over a year-long period from the unique partnership between eRelevance and BTL Aesthetics.
According to the data, per a media release, customers using BTL Aesthetics devices paired with the eRelevance patient marketing service are generating $16,366 in additional monthly revenue; 19 more consultation requests per month; and 20x return on investment (ROI).
“The results of our partnership with BTL clearly show that when a practice is equipped with marketing experts leveraging sophisticated technology, they can quickly pay off their capital investment and generate more repeat business from existing patients,” says eRelevance CEO and Co-founder Bob Fabbio, in the release.
“Through our partnership with eRelevance, we’re going beyond offering state-of-the-art devices for the most advanced treatments,” states John Ferris of BTL Aesthetics, per the release. “We’re significantly improving the way we drive new revenue for customers and strengthening our relationships with those customers. As a result, we’ve established a major advantage in a highly competitive market.”
eRelevance’s exclusive partner program includes a multi-level offering, from service bundles, special pricing and components tailored to each partner.
BTL Aesthetics—which includes brands such as BTL Vanquish ME, BTL Exilis ULTRA, and BTL Cellutone—offers practices options for its equipment bundled with the eRelevance service, as well as free trials and preferred pricing.
[Source(s): eRelevance Corp, BTL Aesthetics]
